Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
Clinical trial NCT04829435 · COMPLETED
Trial details
- NCT number
- NCT04829435
- Sponsor
- Allena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2021-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.